Bio Protocol vs Flow — how do they compare? Bio Protocol trades at Rp439.78 (market cap Rp982,55M, Rp166,27M 24h volume), while Flow trades at Rp578.59 (market cap Rp976,52M, Rp106,02M 24h volume). The key difference: Bio Protocol and Flow are close in size by market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Flow's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Flow for 70 Days on average.
| BIO | FLOW | |
|---|---|---|
Market Cap | Rp982,55M | Rp976,52M |
Volume (24h) | Rp166,27M | Rp106,02M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,7B FLOW |
Typical Hold Time | 17 Days | 70 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Flow is currently trading at Rp585.25 with a market cap of Rp981.29M, showing bullish technical signals across moving averages and oscillators. The token is positioned near the pivot point of Rp568 with immediate resistance at Rp610. Recent on-chain data shows a healthy hold time of 70 days, indicating strong holder conviction despite the ongoing legal investigations surrounding the Flow Foundation.
Overall outlook remains cautiously optimistic with strong technical momentum but significant legal overhang. Key opportunity lies in potential protocol developments and ecosystem growth, while major risks include regulatory scrutiny and the ongoing securities investigation that could impact token valuation and market sentiment.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Flow is a fast, decentralized, and developer-friendly blockchain, designed as the foundation for a new generation of games, apps, and the digital assets that power them. Flow is the only layer-one blockchain originally created by a team that has consistently delivered great consumer blockchain experiences. Flow's ecosystem partner includes NBA, Warner Music and UFC.
Read more on FLOW →